3.1 Chain of Infection & Transmission Dynamics

3.1 Chain of Infection & Transmission Dynamics

Understanding the mechanics of pathogen spread is the fundamental foundation of infection prevention and control (IPC). In epidemiological modeling, the transmission of an infectious micro-organism requires an unbroken sequence of biological events known as the Chain of Infection. For a healthcare-associated infection (HAI) or community-acquired disease to occur, six distinct links must connect in sequence. If any single link in this chain is successfully disrupted or broken, infection cannot occur.

Infection preventionists (IPs) utilize this framework to design targeted, multi-layered infection control interventions. Rather than attempting to eradicate microorganisms entirely from healthcare environments—an impossible task—IPs focus on strategically breaking vulnerable links within the chain to prevent patient colonization and clinical infection.

---

The Six Links in the Chain of Infection

[1. Infectious Agent] ➔ [2. Reservoir] ➔ [3. Portal of Exit] ➔ [4. Mode of Transmission] ➔ [5. Portal of Entry] ➔ [6. Susceptible Host]

1. Infectious Agent

The first link is the pathogen itself—the biological micro-organism capable of causing disease. Infectious agents include bacteria, viruses, fungi, parasites, and prions. The ability of an agent to cause clinical disease depends on several intrinsic microbial characteristics:

• Pathogenicity: The capacity of an organism to cause disease in a susceptible host.
• Virulence: The degree of pathogenicity or severity of disease produced by the agent (e.g., toxin production, capsule formation).
• Infectious Dose: The minimum quantity of microorganisms required to initiate infection in a host.
• Viability and Environmental Stability: The ability of the agent to survive outside a host or resist environmental stressors (e.g., bacterial endospores produced by Clostridioides difficile vs. fragile enveloped viruses like HIV).
• Infective Capability / Specificity: Specific surface receptors or adhesins that allow attachment to host cellular target sites.

2. Reservoir

The reservoir is the natural habitat or environment in which an infectious agent normally lives, grows, multiplies, and depends primarily on for survival. Reservoirs are classified into three primary categories:

• Human Reservoirs: Patients, healthcare personnel, or visitors who may be acutely ill (symptomatic) or asymptomatic carriers. Asymptomatic colonization (such as anterior nares colonization with Methicillin-resistant Staphylococcus aureus [MRSA]) presents a major challenge because unrecognised carriers continually shed pathogens into the environment.
• Environmental Reservoirs: Inanimate objects and environmental surfaces in healthcare settings. Examples include contaminated water systems (Legionella pneumophila, Pseudomonas aeruginosa), soil (Bacillus anthracis), damp building materials (Aspergillus species), and medical equipment or high-touch surfaces (fomites such as bedrails, IV pumps, and stethoscopes).
• Animal Reservoirs (Zoonotic): Animals or insects that harbour human pathogens (e.g., rodents carrying hantavirus, birds carrying avian influenza, or bats carrying rabies).

3. Portal of Exit

The portal of exit is the path or mechanism by which an infectious agent leaves its reservoir. In human reservoirs, portals of exit usually correspond to body sites where pathogens are concentrated:

• Respiratory Tract: Droplets or aerosols generated during coughing, sneezing, talking, suctioning, or endotracheal intubation (e.g., Mycobacterium tuberculosis, Influenza, SARS-CoV-2).
• Gastrointestinal Tract: Feces or vomitus (e.g., Norovirus, C. difficile, Salmonella, Hepatitis A).
• Genitourinary Tract: Urine or genital secretions (e.g., Escherichia coli in urinary catheter outflow, Neisseria gonorrhoeae).
• Skin and Mucous Membranes: Desquamated skin squames, wound drainage, or vesicular fluid (e.g., S. aureus, Herpes simplex virus, Scabies).
• Blood and Body Fluids: Percutaneous exposure via contaminated sharps, blood transfusions, or open vascular lines (e.g., Hepatitis B virus [HBV], Hepatitis C virus [HCV], Human Immunodeficiency Virus [HIV]).
• Transplacental: Vertical transmission from mother to fetus across the placenta (e.g., Cytomegalovirus, Rubella, Toxoplasmosis, Zika virus).

4. Mode of Transmission

Once an agent exits the reservoir, it requires a mechanism of transport to travel to a new host. The mode of transmission is the most frequently targeted link for IPC interventions. Transmission mechanisms are classified into direct and indirect routes:

A. Contact Transmission

• Direct Contact: Physical transfer of microorganisms through direct skin-to-skin contact between an infected or colonized individual and a susceptible host (e.g., turning a patient, bathing, or shaking hands).
• Indirect Contact: Personal contact of a susceptible host with a contaminated intermediate inanimate object (fomite), such as unwashed healthcare worker hands, shared medical instruments, blood pressure cuffs, or dirty bedside tables.

B. Droplet Transmission

Occurs when large respiratory droplets (>5 to 10 µm in diameter) containing pathogens are propelled short distances (typically 3 to 6 feet) through the air when an infected person coughs, sneezes, or talks. Because of their size, droplets do not remain suspended in the air for long periods and settle quickly onto environmental surfaces. Transmission occurs when droplets directly land on a susceptible host’s conjunctivae, nasal mucosa, or oral mucosa (e.g., Bordetella pertussis, Neisseria meningitidis, Influenza).

C. Airborne Transmission

Occurs through the dissemination of airborne droplet nuclei (<5 µm in diameter) or small particles containing infectious agents. Because of their small size, these particles remain suspended in air currents for extended periods and can travel over long distances and across ventilation systems. Susceptible hosts inhale these nuclei deep into the pulmonary alveoli (e.g., Mycobacterium tuberculosis, Measles [Rubeola] virus, Varicella-zoster virus).

D. Vehicle-Borne Transmission

Transmission via a single contaminated inanimate medium (vehicle) that indirectly transmits an infectious agent to multiple hosts. Examples include contaminated shared food products (Salmonella), public water supplies (Cryptosporidium), contaminated multi-dose medication vials, or IV fluids (Serratia marcescens).

E. Vector-Borne Transmission

Transmission mediated by living arthropods or invertebrates:

• Mechanical Vector: Passive transport of the pathogen on the vector's body parts (e.g., houseflies transferring enteric bacteria from feces to food).
• Biological Vector: The pathogen undergoes multiplication or essential developmental cycles within the vector before transmission to humans via bites or stings (e.g., Anopheles mosquitoes transmitting Plasmodium malaria; Ixodes ticks transmitting Borrelia burgdorferi).

5. Portal of Entry

The portal of entry is the site or pathway through which an infectious agent enters the susceptible host. The portal of entry often corresponds to the same anatomical site as the portal of exit. Common entry portals include:

• Non-intact skin (abrasions, surgical incisions, burn wounds, eczema).
• Mucous membranes (eyes, nose, mouth).
• Respiratory tract (inhalation of aerosolized droplets or dust).
• Gastrointestinal tract (ingestion of contaminated food or water).
• Invasively breached barriers (central venous catheters, urinary catheters, endotracheal tubes, surgical drains).

6. Susceptible Host

The final link in the chain is a human host who lacks sufficient immunity or physiological resistance to withstand infection by a specific pathogen. Host susceptibility is influenced by a complex interplay of intrinsic and extrinsic factors:

• Intrinsic Factors: Extremes of age (neonates with immature immune systems, elderly individuals with immunosenescence), genetic predisposition, underlying chronic medical conditions (diabetes mellitus, chronic kidney disease, cirrhosis), and malnutrition.
• Extrinsic Factors: Immunosuppressive medical therapies (chemotherapy, systemic corticosteroids, biologic agents), invasive medical devices (indwelling vascular and urinary catheters), surgical procedures, extended hospital stays, and disruption of normal commensal microflora due to broad-spectrum antibiotic therapy.

---

Breaking the Chain of Infection

Infection control interventions are specifically designed to sever one or more links in the chain of infection. The table below illustrates how evidence-based IPC practices align with specific links to prevent disease transmission: